SNTI
SNTI
NASDAQ · Biotechnology

Senti Biosciences Inc

$0.45
+0.07 (+16.93%)
As of Aug 14, 10:18 PM ET ·
Financial Highlights (FY 2026)
Revenue
31.5K
Net Income
-86,030,440
Gross Margin
Profit Margin
-279,263.6%
Rev Growth
-82.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 52.7% 52.7%
Operating Margin -312,631.8% -281,369.2% 7.9% 7.6%
Profit Margin -279,263.6% -265,300.5% 8.0% 5.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 31.5K 182.5K 15.18M 16.45M
Gross Profit 8.01M 8.68M
Operating Income -98,422,749 -513,509,994 1.19M 1.25M
Net Income -86,030,440 -448,854,469 1.21M 962.0K
Gross Margin 52.7% 52.7%
Operating Margin -312,631.8% -281,369.2% 7.9% 7.6%
Profit Margin -279,263.6% -265,300.5% 8.0% 5.9%
Rev Growth -82.8% -82.8% +1.7% +13.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 3.21M 3.14M
Total Equity 9.87M 10.49M
D/E Ratio 0.33 0.30
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -92,481,306 -509,317,337 1.98M 2.22M
Free Cash Flow 1.07M 1.04M